CHASE WAGNER: Open Payments
NPI 1528510930 · ESCONDIDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 57 payments from 18 companies in 2025. Trend: 2023 $1,117 · 2024 $1,267 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $238 |
| PFIZER INC. | 12 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $123 |
| Merck Sharp & Dohme LLC | 4 | $107 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Boston Scientific Corporation | 2 | $43 |
| ABIOMED | 2 | $41 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $28 |
Products named: LEQVIO, ELIQUIS, JARDIANCE, VERQUVO, WATCHMAN FLX, AMVUTTRA, CAMZYOS, DEFINITY.
Industry payments across CA — which companies pay providers there.
